Health
South Korea to Introduce Medication Abortion Pills as Early as First Quarter 2025
Government announces plan to approve mifepristone for pregnancies up to nine weeks, with doctors to dispense directly for two years. Medical and religious groups raise concerns over incomplete legal framework....
Antengene's ATG-201 Autoimmune Therapy Receives Australian Clinical Trial Approval
Biotech company Antengene has secured regulatory clearance in Australia to begin Phase I trials of ATG-201, a bispecific antibody targeting B cell-related autoimmune diseases, marking the therapy's expansion beyond China into international markets....
FDA Clears Orum Therapeutics to Begin Testing Novel Leukemia Drug ORM-1153
The FDA has authorized Orum Therapeutics to proceed with human trials of ORM-1153, a first-in-class degrader-antibody conjugate targeting acute myeloid leukemia and other blood cancers. The Phase 1 study is expected to launch by year-end 2026....